Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, has announced its plans to release financial results for the second quarter ended June 30, 2024 on Monday, August 12th, 2024, after market close. The company will host a conference call and webcast at 4:30 p.m. ET to review the financial and operating results.
Investors can participate by dialing 1-877-407-9039 (domestic) or 1-201-689-8470 (international) with Conference ID# 13747356. A live webcast will be available on the company's website, and the event will be archived for one year after the live webcast.
Eyenovia, Inc. (NASDAQ: EYEN), un'azienda oftalmica con due prodotti approvati dalla FDA e un progetto in fase avanzata per la miopia progressiva pediatrica, ha annunciato i suoi piani per rilasciare i risultati finanziari per il secondo trimestre chiuso il 30 giugno 2024 il lunedì 12 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una chiamata conferenza e webcast alle 16:30 ET per esaminare i risultati finanziari e operativi.
Gli investitori possono partecipare componendo il numero 1-877-407-9039 (nazionale) o 1-201-689-8470 (internazionale) con il Codice Conferenza #13747356. Un webcast dal vivo sarà disponibile sul sito web dell'azienda, e l'evento sarà archiviato per un anno dopo il webcast dal vivo.
Eyenovia, Inc. (NASDAQ: EYEN), una empresa oftálmica con dos productos aprobados por la FDA y un activo en etapa avanzada para la miopía progresiva pediátrica, ha anunciado sus planes para publicar resultados financieros para el segundo trimestre que finalizó el 30 de junio de 2024 el lunes 12 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo una llamada de conferencia y webcast a las 4:30 p.m. ET para revisar los resultados financieros y operativos.
Los inversores pueden participar marcando el 1-877-407-9039 (nacional) o el 1-201-689-8470 (internacional) con el ID de Conferencia #13747356. Se dispondrá de un webcast en vivo en el sitio web de la empresa, y el evento se archivará durante un año después del webcast en vivo.
Eyenovia, Inc. (NASDAQ: EYEN), ophthalmic 회사로 FDA 승인을 받은 두 개의 제품과 소아 진행성 근시를 위한 후기 단계 자산을 보유하고 있는 이 회사가 2024년 6월 30일 종료된 2분기 재무 결과를 2024년 8월 12일 월요일에 시장 마감 후 발표할 계획이라고 발표했습니다. 이 회사는 동부 표준시 오후 4시 30분에 재무 및 운영 결과를 검토하기 위해 전화 회의 및 웹캐스트를 개최합니다.
투자자는 컨퍼런스 ID# 13747356과 함께 국내 1-877-407-9039 또는 국제 1-201-689-8470으로 전화하여 참여할 수 있습니다. 회사 웹사이트에서 생중계가 제공되며, 생중계 이후 1년 동안 이벤트가 보관될 예정입니다.
Eyenovia, Inc. (NASDAQ: EYEN), une entreprise ophtalmique avec deux produits approuvés par la FDA et un actif en phase avancée pour la myopie progressive pédiatrique, a annoncé ses plans de publier les résultats financiers du deuxième trimestre clos le 30 juin 2024 le lundi 12 août 2024, après la clôture des marchés. L'entreprise organisera un appel-conférence et un webcast à 16h30, heure de l'Est pour examiner les résultats financiers et opérationnels.
Les investisseurs peuvent participer en composant le 1-877-407-9039 (domestique) ou le 1-201-689-8470 (international) avec l'identifiant de conférence #13747356. Un webcast en direct sera disponible sur le site Web de l'entreprise, et l'événement sera archivé pendant un an après le webcast en direct.
Eyenovia, Inc. (NASDAQ: EYEN), ein Augenheilkunde-Unternehmen mit zwei von der FDA zugelassenen Produkten und einem späten Vermögenswert in der pädiatrischen progressiven Myopie, hat seine Pläne bekannt gegeben, finanzielle Ergebnisse für das am 30. Juni 2024 endende zweite Quartal am Montag, den 12. August 2024, nach Börsenschluss zu veröffentlichen. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und Webcast abhalten, um die finanziellen und betrieblichen Ergebnisse zu überprüfen.
Investoren können teilnehmen, indem sie 1-877-407-9039 (inland) oder 1-201-689-8470 (international) mit der Konferenz-ID #13747356 wählen. Ein Live-Webcast wird auf der Unternehmenswebsite verfügbar sein, und die Veranstaltung wird ein Jahr lang nach dem Live-Webcast archiviert.
- None.
- None.
Company to host an investor conference call and webcast at 4:30pm EDT
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today announced that the Company will release financial results for the second quarter ended June 30, 2024 on Monday, August 12th, 2024, after the markets close. Following the release, Eyenovia management will host a conference call and webcast at 4:30 p.m. ET to review the financial and operating results.
Participants should dial 1-877-407-9039 (domestic) or 1-201-689-8470 (international) and reference Conference ID# 13747356.
To access the Call me™ feature, which avoids having to wait for an operator, click here.
A live webcast of the conference call will also be available here and on the investor relations page of the Company's corporate website at www.eyenovia.com.
After the live webcast, the event will be archived on Eyenovia’s website for one year.
About Eyenovia, Inc.
Eyenovia, Inc. is an ophthalmic technology company commercializing Mydcombi™ (tropicamide and phenylephrine hydrochloride ophthalmic spray)
For more information, visit Eyenovia.com.
The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.
Eyenovia Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenovia.com
Eyenovia Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
(646) 751-4363
Eyenovia Media Contact:
Eyenovia, Inc.
Norbert Lowe
Vice President, Commercial Operations
nlowe@eyenovia.com
FAQ
When will Eyenovia (EYEN) report its Q2 2024 financial results?
How can investors participate in Eyenovia's (EYEN) Q2 2024 earnings call?
What time is Eyenovia's (EYEN) Q2 2024 earnings conference call scheduled for?
How many FDA-approved products does Eyenovia (EYEN) currently have?
